Compare ALH & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALH | INDV |
|---|---|---|
| Founded | 1908 | N/A |
| Country | United States | United States |
| Employees | 3973 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.7B |
| IPO Year | N/A | 2014 |
| Metric | ALH | INDV |
|---|---|---|
| Price | $24.97 | $32.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $30.88 | N/A |
| AVG Volume (30 Days) | 904.6K | ★ 2.2M |
| Earning Date | 05-26-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 1.64 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $7.42 | N/A |
| Revenue Next Year | $5.88 | N/A |
| P/E Ratio | $35.43 | ★ $20.09 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $18.64 | $8.69 |
| 52 Week High | $27.48 | $38.00 |
| Indicator | ALH | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 72.16 | 55.14 |
| Support Level | $20.63 | $31.70 |
| Resistance Level | $25.11 | $32.42 |
| Average True Range (ATR) | 0.93 | 1.18 |
| MACD | 0.55 | 0.39 |
| Stochastic Oscillator | 95.00 | 73.89 |
Alliance Laundry Holdings Inc is a designer and manufacturer of commercial laundry systems, serving diverse international markets. The company offers premium, durable laundry equipment under brands like Speed Queen, UniMac, Huebsch, Primus, IPSO, and others. It serves commercial laundry needs across healthcare, hotels, laundromats, and residential markets. Revenue is generated through the sale of commercial-grade laundry systems and service parts across two geographic segments, North America and International, and into the three end markets of OPL, Vended, and Commercial In-Home.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).